<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine the relation between factor V Leiden and <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease (BD), which is described as <z:hpo ids='HP_0011010'>chronic</z:hpo> relapsing <z:hpo ids='HP_0002633'>vasculitis</z:hpo> with pathogenetic mechanisms that seem to be related to <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> pathways </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Using polymerase chain reaction, the <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e> was investigated in 44 patients with BD, of which 5 had thrombotic histories </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Ten patients were found to have the <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>This frequency (22.7%) was higher than that of our general population (7.1 %) (p &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>Of the 5 patients with BD with thrombotic histories, 3 (60%) had <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e> (one homozygote, 2 heterozygote), while 7 of 39 (17.9%) patients with no thrombotic history had the <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e> (2 homozygotes, 5 heterozygotes) </plain></SENT>
<SENT sid="5" pm="."><plain>There is no statistical difference in the frequency of the factor V mutation between patients with BD with no <z:mp ids='MP_0005048'>thrombosis</z:mp> and the control group </plain></SENT>
<SENT sid="6" pm="."><plain>The frequency of <z:mp ids='MP_0005048'>thrombosis</z:mp> in BD with and without <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e> was (3/10) 30% and (2/34) 5.9%, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: These findings suggest that homozygosity or heterozygosity for factor V Leiden is not always associated with occurrence of <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> in BD, but it may be a contributing risk factor for venous <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> in these patients </plain></SENT>
</text></document>